Roberts Eiry's Form 4 filing
Neurocrine Biosciences Inc (NBIX) · filed Feb 14, 2025
- Accession no.
- 0000914475-25-000069
- Filed
- Feb 14, 2025
- Trade date
- Feb 12-14, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 5 derivative transactions. Open-market sales total $258.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Roberts EiryCIK 0001727606 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Common Stock | MOption exerciseAcquired | +2,113 | $0.00 | $0 | 35,366 | Direct | |
| Feb 13, 2025 | Common Stock | SSaleDisposed | −1,114 | $116.90 | −$130,226.6 | 34,252 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseAcquired | +1,120 | $0.00 | $0 | 35,372 | Direct | |
| Feb 13, 2025 | Common Stock | SSaleDisposed | −604 | $116.74 | −$70,510.96 | 34,768 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseAcquired | +1,372 | $0.00 | $0 | 36,140 | Direct | |
| Feb 14, 2025 | Common Stock | SSaleDisposed | −500 | $115.04 | −$57,520 | 35,640 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | Common Stock | AGrant or awardAcquired | +43,261 | $0.00 | $0 | 43,261 | Direct | |
| Feb 12, 2025 | Common Stock | AGrant or awardAcquired | +8,108 | $0.00 | $0 | 8,108 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseDisposed | −2,113 | $0.00 | $0 | 4,227 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseDisposed | −1,120 | $0.00 | $0 | 3,363 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseDisposed | −1,372 | $0.00 | $0 | 4,115 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.